stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Shares outstanding
LeMaitre Vascular, Inc.'s shares outstanding at the end of fiscal 2025 was $22.9M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $23.1M. Over the past ten years it has ranged from $18.3M (fiscal 2015) to $22.9M (fiscal 2025) — the current reading is the highest in ten years. LeMaitre Vascular, Inc. ranks 36th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $22.9M | 0.66% |
| FY2024 | $22.8M | 1.59% |
| FY2023 | $22.4M | 1.14% |
| FY2022 | $22.2M | 3.24% |
| FY2021 | $21.5M | 4.86% |
| FY2020 | $20.5M | 0.75% |
| FY2019 | $20.3M | 0.41% |
| FY2018 | $20.2M | 1.04% |
| FY2017 | $20.0M | 4.12% |
| FY2016 | $19.2M | 5.05% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $23.1M | (5.95%) |
| Jun 2026 | $24.5M | 6.51% |
| Mar 2026 | $23.0M | 0.44% |
| Dec 2025 | $22.9M | (6.00%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| STVN Stevanato Group S.p.A. compare | $273.1M |
| XRAY DENTSPLY SIRONA Inc. compare | $199.2M |
| WRBY Warby Parker Inc. compare | $126.1M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| KMTS Kestra Medical Technologies, Ltd. compare | $58.6M |
| STAA STAAR Surgical Company compare | $51.4M |
| ATRC AtriCure, Inc. compare | $49.8M |
| AZTA Azenta, Inc. compare | $45.3M |
| LMAT LeMaitre Vascular, Inc. | $23.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement